搜索
Journey Medical Corp
DERM添加自选
6.550USD
-0.100-1.50%
交易中 （美东）报价延迟15分钟
177.80M总市值
亏损市盈率 TTM
关于 Journey Medical Corp 公司
Journey Medical Corporation is a commercial-stage pharmaceutical company. The Company is focused on selling and marketing of the United States Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the United States. Its marketed products, which have been approved FDA for sale in the United States, include Qbrexza, Accutane, Amzeeq, Zilxi, Exelderm Cream and Solution, Targadox, and Luxamend. Qbrexza is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis. Accutane is an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne. Targadox is an oral doxycycline drug for adjunctive therapy for severe acne. Luxamend is a water-based emulsion formulated to provide moist healing environment.
Journey Medical Corp 简介
公司代码DERM
公司名称Journey Medical Corp
上市日期Nov 12, 2021
CEOMaraoui (Claude)
员工数量41
证券类型Ordinary Share
年结日Nov 12
公司地址9237 E Via De Ventura Blvd., Suite 105
城市SCOTTSDALE
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编85258
电话14804346670
网址https://journeymedicalcorp.com/
公司代码DERM
上市日期Nov 12, 2021
CEOMaraoui (Claude)
Journey Medical Corp公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Claude Maraoui
Mr. Claude Maraoui
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.29M
+10.02%
Mr. Claude Maraoui
Mr. Claude Maraoui
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.29M
+10.02%
Mr. Ramsey Alloush
Mr. Ramsey Alloush
Chief Operating Officer, General Counsel, Corporate Secretary
Chief Operating Officer, General Counsel, Corporate Secretary
470.73K
+32.73%
Mr. Ramsey Alloush
Mr. Ramsey Alloush
Chief Operating Officer, General Counsel
Chief Operating Officer, General Counsel
470.73K
+32.73%
Dr. Lindsay A. Rosenwald, M.D.
Dr. Lindsay A. Rosenwald, M.D.
Executive Chairman of the Board
Executive Chairman of the Board
340.44K
+2.94%
Dr. Lindsay A. Rosenwald, M.D.
Dr. Lindsay A. Rosenwald, M.D.
Executive Chairman of the Board
Executive Chairman of the Board
340.44K
+2.94%
Mr. Joseph Benesch, CPA
Mr. Joseph Benesch, CPA
Chief Financial Officer, Corporate Controller
Chief Financial Officer, Corporate Controller
187.57K
+46.27%
Mr. Joseph Benesch, CPA
Mr. Joseph Benesch, CPA
Chief Financial Officer, Corporate Controller
Chief Financial Officer, Corporate Controller
187.57K
+46.27%
Mr. Neil Herskowitz
Mr. Neil Herskowitz
Independent Director
Independent Director
141.44K
+35.35%
Ms. Miranda Jayne Toledano
Ms. Miranda Jayne Toledano
Independent Director
Independent Director
141.44K
+35.35%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Claude Maraoui
Mr. Claude Maraoui
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.29M
+10.02%
Mr. Claude Maraoui
Mr. Claude Maraoui
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.29M
+10.02%
Mr. Ramsey Alloush
Mr. Ramsey Alloush
Chief Operating Officer, General Counsel, Corporate Secretary
Chief Operating Officer, General Counsel, Corporate Secretary
470.73K
+32.73%
Mr. Ramsey Alloush
Mr. Ramsey Alloush
Chief Operating Officer, General Counsel
Chief Operating Officer, General Counsel
470.73K
+32.73%
Dr. Lindsay A. Rosenwald, M.D.
Dr. Lindsay A. Rosenwald, M.D.
Executive Chairman of the Board
Executive Chairman of the Board
340.44K
+2.94%
Dr. Lindsay A. Rosenwald, M.D.
Dr. Lindsay A. Rosenwald, M.D.
Executive Chairman of the Board
Executive Chairman of the Board
340.44K
+2.94%
常见问题
Journey Medical Corp的前五大股东是谁？
Journey Medical Corp 的前五大股东如下：Mr. Claude Maraoui
有多少机构持有Journey Medical Corp(DERM)的股份？
截至2026Q1，共有137家机构持有Journey Medical Corp的股份，合计持有的股份价值约为12.08M，占公司总股份的56.62%。与2025Q4相比，机构持股有所增加，增幅为2740272.00。
哪个业务部门对Journey Medical Corp的收入贡献最大？
在2026Q1，Qbrexa业务部门对Journey Medical Corp的收入贡献最大，创收25.01M，占总收入的40.85%。